semaglutide patent protection Semaglutide's expires today. What does it mean for patients, pharma players and Novo Nordisk? What is the patent landscape

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

Jessica Shepherd said

Everyones hair has a cycle, but the length of the cycle can vary from individual to individual and can be disrupted by a number of factors including age and ill health, to name just a couple of causes

20 (S3), 32743281 (2017)

The manufacturing of vitamin b1, b6, and b12 injection requires sophisticated and highly aseptic equipment for each step from production till packaging

Peter Lurie, former FDA official now at the Center for Science in the Public Interest, has warned that allowing compounding of peptides without adequate clinical testing creates a profound threat to the FDAs drug-vetting system